TH, T., JW, L., YJ, H., SW, L., TY, H., KY, W., & FC, L. (2025). Molecular Hydrogen Therapy in Rheumatoid Arthritis: A Case Report on the Amelioration of Methotrexate-induced Myelosuppression and Immune Modulation. In vivo (Athens, Greece), 39(4), 2186. https://doi.org/10.21873/invivo.14014
Chicago Style (17th ed.) CitationTH, Tu, Lu JW, Ho YJ, Lui SW, Hsieh TY, Wang KY, and Liu FC. "Molecular Hydrogen Therapy in Rheumatoid Arthritis: A Case Report on the Amelioration of Methotrexate-induced Myelosuppression and Immune Modulation." In Vivo (Athens, Greece) 39, no. 4 (2025): 2186. https://doi.org/10.21873/invivo.14014.
MLA (9th ed.) CitationTH, Tu, et al. "Molecular Hydrogen Therapy in Rheumatoid Arthritis: A Case Report on the Amelioration of Methotrexate-induced Myelosuppression and Immune Modulation." In Vivo (Athens, Greece), vol. 39, no. 4, 2025, p. 2186, https://doi.org/10.21873/invivo.14014.